当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Inflammopharmacology杂志
Inflammopharmacology
基本信息
期刊名称 Inflammopharmacology
INFLAMMOPHARMACOLOGY
期刊ISSN 0925-4692
期刊官方网站 https://www.springer.com/10787
是否OA No
出版商 Birkhauser Verlag Basel
出版周期 6 issues per year
文章处理费 登录后查看
始发年份 1991
年文章数 263
影响因子 4.6(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 IMMUNOLOGY 免疫学3区
TOXICOLOGY 毒理学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 8.0 0.952 1.006
Medicine
Pharmacology (medical)
37/272 86%
Pharmacology, Toxicology and Pharmaceutics
Pharmacology
70/313 77%
Immunology and Microbiology
Immunology
80/236 66%
补充信息
自引率 4.3%
H-index 45
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0925-4692%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/iphm
收稿范围
Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:

Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states
Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs
Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents
Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain
Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs
Muscle-immune interactions during inflammation: mechanisms of inflammation and anti-inflammatory actions of therapeutic agents on skeletal muscle under conditions of aging or injury.
Safety and efficacy of Non-prescription (OTC) and prescription NSAIDs and Analgesics
收录体裁
投稿指南 https://link.springer.com/journal/10787/submission-guidelines
投稿模板
参考文献格式
编辑信息

Editor-in-Chief

Kim D. Rainsford
Biomedical Research Centre
Sheffield Hallam University
Howard Street
Sheffield, S1 1WB
United Kingdom
and
Faculty of Health and Medical Sciences
Adelaide Medical School
North Terrace, Adelaide
South Australia
Australia, 5005
E-mail: editor@inflammopharmacology.com

Deputy Editors

Omar M.E. Abdel-Salam
National Research Center, Cairo, Egypt

Phillip J. Berry
Diabetes Medical Team, MSD, Hoddeston, England, UK

Lyndsey E. Collins-Praino
Discipline of Anatomy and Pathology
University of Adelaide
Adelaide, SA, Australia

Klára Gyires
Semmelweis University
Department of Pharmacology and Pharmacotherapy
Budapest, Hungary

Parto S. Khansari
Stony Brook School of Pharmacy and Pharmaceutical Sciences
Stony Brook, NY, USA

Walter F. Kean
Department of Medicine
McMaster University 
Hamilton, Ontario, Canada

David R. Haynes
Discipline of Anatomy and Pathology
University of Adelaide
Adelaide, SA, Australia

Rajan Radhakrishnan
College of Medicine
Mohammed Bin Rashid University of Medicine and Health Sciences
Dubai, United Arab Emirates

Eugene Roscioli
Royal Adelaide Hospital
Department of Thoracic Medicine
Adelaide, SA, Australia

Beatá Sperlágh
Hungarian Academy of Sciences
Budapest, Hungary

Luis Vitetta
Medlab Clinical Ltd. and The University of Sydney Medical School
Alexandria, NSW, Australia

Section Editors

Ageing, Muscle and Exercise
Kathryn H. Myburgh and Carine Smith
Department of Physiological Sciences, Stellenbosch University, South Africa

Biologics

Drug-Disease Interactions - Conditional Pharmacology
Michael C. Powanda 
M/P Biomedical Consultants LLC, Mill Valley, CA, USA

Michael W. Whitehouse
School of Medicine, Griffith University, Brisbane, Qld., Australia

Gastroenterology
Klára Gyires, Semmelweis University, Budapest, Hungary

General Pharmacology

HECPS Representative
Beatá Sperlágh

Hungarian Academy of Sciences, Budapest, Hungary

Inflammation in Dementias
Joel S. Ross, RHNanopharmaceutics LLC, Monmouth Beach, NJ, USA

Inflammatory Aspects of Metabolic Diseases and Diabetes
Linh Ho
Department of Pharmaceutical and Biomedical Sciences, California Northstate University, University College of Pharmacy, Sacramento, CA, USA

Inflammatory Mechanisms
Diane Cooper
The William Harvey Research Institute, Barts and The Queen Mary's School of Medicine and Dentistry, London, UK

Inflammatory Respiratory Diseases
Eugene Roscioli
Royal Adelaide Hospital, Department of Thoracic Medicine, Adelaide, SA, Australia

Natural Products
Ian Cock
School of Natural Sciences, Griffith University, Brisbane, Qld., Australia

Neuroinflammation
Parto S. Khansari
Stony Brook School of Pharmacy and Pharmaceutical Sciences, Stony Brook, NY, USA

New Drug Developments

Stefan A. Laufer
Pharmaceutical Institute, University of Tübingen, Tübingen, Germany

Ian M. Hunneyball
Evotec Inc, Abingdon, Oxon, United Kingdom

Burkhard Hinz
Institute for Pharmacology and Toxicology, University Medicine Rostock, Rostock, Germany


Oral and Maxillofacial Pharmacology
Thomas Dietrich
Birmingham Dental Hospital & University of Birmingham, Birmingham, United Kingdom

Pharmacoepidemiology and OTC Drugs
Phillip J. Berry
Diabetes Medical Team, MSD, Hoddeston, England, UK

Pharmaceutics and Topical Delivery of Analgesics
Michael Roberts
The University of Queensland
Diamantina Institute, School of Medicine, Brisbane, Qld., Australia

Probiotics and Microbiome Studies in Gastroenterology
Ingvar Bjarnason
King's College Hospital and Medical School, London, United Kingdom

Luis Vitetta
Medlab Clinical Ltd. and The University of Sydney Medical School, Alexandria, NSW, Australia


Editorial Consultants

Brian A. Callingham, Cambridge, UK
Richard H. Hunt, Hamilton, ON, Canada
Walter F. Kean, Hamilton, ON, Canada
Michael P. Seed, London, UK
Jagdish N. Sharma, Safat, Kuwait
Sandor Szabo, Los Angeles, CA, USA
Michael W. Whitehouse, Brisbane, Qld., Australia

Editorial Board

Omar M.E. Abdel-Salam, Cairo, Egypt
Tetsuo Arakawa, Osaka, Japan
Samir S. Ayoub, London, UK
Ingvar Bjarnason, London, UK
Joanne Bowen, Adelaide, SA, Australia
Jonas Kure Buer, Oslo, Norway
Melissa Cantley, Adelaide, SA, Australia
Cho Hin Cho, Hong Kong, China
Nigel Farrow, Adelaide, SA, Australia
Ludmila P. Filaretova, St.Petersburg, Russia
Leo R. Fitzpatrick, Elk Grove, CA, USA
Isaac Ginsburg, Jerusalem, Israel
Rodrigo Guabiraba, Nouzilly, France
Colin Kean, Hamilton, ON, Cananda
Julie Keeble, London, UK
Chak-Sing Lau, Hong Kong, China
Thomas Leung, Hong Kong, China
Xiaowen Liang, Brisbane, Qld., Australia
Leonard M. Lichtenberger, Houston, TX, USA
Xin Liu, Brisbane, Qld., Australia
Hugo F. Miranda, Santiago, Chile
Nicholas Moore, Bordeaux, France
Andrew J.K. Östör,Malvern, Vic, Australia
Michael C. Powanda, Mill Valley, CA, USA
Rajan Radhakrishnan, Dubai, United Arab Emirates
Saravanan Subramanian, Omaha, NE, USA
Murtaza M. Tambuwala, Ulster, UK
Cijo George Vazhappilly, Ras Al Khaimah, UAE


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug